Home Healthcare Pharmaceuticals Menopause Market

Menopause Market Size, Share & Trends Analysis Report By Treatment Type (Dietary Supplements, Hormone Therapies, Non-hormonal Therapies), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Other Distribution Channels) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 03, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
  7. North America Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  8. Europe Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. France
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  9. APAC Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. China
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. India
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  10. Middle East and Africa Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  11. LATAM Menopause Market Size Analysis
    1. Introduction
    2. Menopause Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Dietary Supplements
        1. Multivitamin Supplements
        2. Phytoestrogen Supplement
        3. Antioxidant Supplements
        4. Other Supplements
      2. Hormone Therapies
        1. Progestin-only Medicines
        2. Estrogen-only Medicines
        3. Other Therapies
        4. DNA Polymerases
      3. Non-hormonal Therapies
        1. Gabapentinoids
        2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
        3. Selective Serotonin Reuptake Inhibitors (SSRI)
        4. Other Non-hormonal Therapies
    3. Menopause Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other Distribution Channels
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
  12. Competitive Landscape
    1. Menopause Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson Inc.
    3. Merck & Co., Inc.
    4. Bayer AG
    5. AbbVie Inc.
    6. Novartis AG
    7. Novo Nordisk A/S
    8. Lilly
    9. Teva Pharmaceutical Industries Ltd.
    10. GSK plc
    11. Astellas Pharma Inc.
    12. Sanofi
    13. Pure Encapsulations, LLC
    14. Reddy’s Laboratories Ltd.
    15. Theramex 
    16. Midi Health
    17. Lindus Health
    18. Frieda Health
    19. Ipsen S.A.
    20. Endo International plc
    21. Hims & Hers Health
    22. Bonafide Health
    23. Elektra Health
    24. Oscar Health
    25. Hoag
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Menopause Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 3: Global Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 4: North America Menopause Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 6: North America Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 7: U.S. Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 8: U.S. Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: Canada Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 10: Canada Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 11: Europe Menopause Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 13: Europe Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 14: U.K. Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 15: U.K. Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 16: Germany Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 17: Germany Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 18: France Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 19: France Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 20: Spain Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 21: Spain Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Italy Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 23: Italy Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 24: Russia Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 25: Russia Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 26: Nordic Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 27: Nordic Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Benelux Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 29: Benelux Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 30: Rest of Europe Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 31: Rest of Europe Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 32: APAC Menopause Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 34: APAC Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 35: China Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 36: China Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Korea Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 38: Korea Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 39: Japan Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 40: Japan Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 41: India Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 42: India Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Australia Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 44: Australia Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 45: Taiwan Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 46: Taiwan Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 47: South East Asia Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 48: South East Asia Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 49: Rest of Asia-Pacific Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 50: Rest of Asia-Pacific Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 51: Middle East and Africa Menopause Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 52: Middle East and Africa Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 54: UAE Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 55: UAE Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Turkey Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 57: Turkey Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 58: Saudi Arabia Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 59: Saudi Arabia Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 60: South Africa Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 61: South Africa Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Egypt Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 63: Egypt Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 64: Nigeria Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 65: Nigeria Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 66: Rest of MEA Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 67: Rest of MEA Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: LATAM Menopause Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 69: LATAM Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 70: LATAM Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: Brazil Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 72: Brazil Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 73: Mexico Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 74: Mexico Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 75: Argentina Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 76: Argentina Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 77: Chile Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 78: Chile Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 79: Colombia Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 80: Colombia Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: Rest of LATAM Menopause Market Size and Forecast By Treatment Type - 2022-2034 (USD Billion)

Table 82: Rest of LATAM Menopause Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.